Protection of brain development by antenatal magnesium sulphate for infants born preterm
Cerebral palsy (CP) remains the most significant neurological disorder associated with
preterm birth. It disrupts quality of life and places huge cost burdens on society. Antenatal …
preterm birth. It disrupts quality of life and places huge cost burdens on society. Antenatal …
Antenatal magnesium sulphate neuroprotection in the preterm infant
Very preterm infants have high rates of neurological impairments and disabilities. These
rates have not diminished as the survival rates have improved. Basic science research …
rates have not diminished as the survival rates have improved. Basic science research …
[HTML][HTML] Fetal neuroprotection by magnesium sulfate: from translational research to clinical application
Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …
associated brain injury and adverse neurological outcomes remain a persistent challenge …
[HTML][HTML] Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …
[HTML][HTML] Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: an individual participant data meta-analysis
Background Babies born preterm are at an increased risk of dying in the first weeks of life,
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …
and those who survive have a higher rate of cerebral palsy (CP) compared with babies born …
Antenatal magnesium sulfate: neuro-protection for preterm infants
S Oddie, DJ Tuffnell, W McGuire - … of Disease in Childhood-Fetal and …, 2015 - fn.bmj.com
The neuro-protective effect of antenatal magnesium sulfate on very preterm infants has been
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …
Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial
ContextPrenatal magnesium sulfate may reduce the risk of cerebral palsy or death in very
preterm infants. ObjectiveTo determine the effectiveness of magnesium sulfate given for …
preterm infants. ObjectiveTo determine the effectiveness of magnesium sulfate given for …
[HTML][HTML] Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
PE Bouet, S Brun, H Madar, AL Baisson, V Courtay… - Scientific Reports, 2015 - nature.com
The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …
[HTML][HTML] A systematic review of magnesium sulfate for perinatal neuroprotection: what have we learnt from the past decade?
R Galinsky, JM Dean, I Lingam, NJ Robertson… - Frontiers in …, 2020 - frontiersin.org
There is an important unmet need to improve long term outcomes of encephalopathy for
preterm and term infants. Meta-analyses of large controlled trials suggest that maternal …
preterm and term infants. Meta-analyses of large controlled trials suggest that maternal …
Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection
SK Basu, V Chickajajur, V Lopez, A Bhutada, M Pagala… - 2012 - degruyter.com
Background: Antenatal magnesium sulfate can potentially reduce the risk of cerebral palsy
in neonates delivered between 24 and 32 weeks of gestational age. Some studies using …
in neonates delivered between 24 and 32 weeks of gestational age. Some studies using …